Skip to main content
. 2013 Nov 5;9(5):858–864. doi: 10.5114/aoms.2013.38679

Table I.

Demographics, epilepsy and treatment characteristics

Characteristics Overall (n = 309) Newer (n = 76) Oldera (n = 233) Mono (n = 188) Poly (n = 121)
Genderd
 Female, n (%) 157 (50.8) 45 (59.2) 112 (48.1) 95 (50.5) 62 (51.2)
 Male, n (%) 151 (48.9) 30 (39.5) 121 (51.9) 92 (48.9) 59 (48.8)
Age [years]e
 Mean ± SD 23.92 ±16.72 21.53 ±13.35 24.70 ±17.63 21.89 ±16.66 27.02 ±16.41
 Range 4–82 4–73 4–82 4–79 4–82
Age at onset [years]e
 Mean ± SD 13.76 ±13.46 12.57 ±10.69 14.15 ±14.24 14.34 ±13.67 12.88 ±13.12
 Range 1–78 1–78 1–78 1–72 1–78
Duration since last seizure [days]b, e
 Median(Q1–Q3) 183(30–517) 183(32–365) 183(25–525) 274(84–660) 66(10–216)
Duration since last treatment modification [months]b
 Median(Q1–Q3) 10(5–19) 8(5–15) 11(5–22) 11(6–22) 8(5–18)
Type of seizurec, f, n (%)
 POS only 227 (73.5) 58 (76.3) 169 (72.5) 129 (68.6) 98 (81.0)
 PGS only 75 (24.3) 17 (22.4) 58 (24.9) 55 (29.3) 20 (16.5)
 POS & PGS 3 (1.0) 3 (1.3) 3 (2.5)
AED by medication, n (%)
 CBZ 86 (27.8) 86 (26.9) 50 (26.6) 36 (29.8)
 CLN 3 (1.0) 3 (1.3) 3 (2.5)
 GBP 13 (4.2) 7 (9.2) 6 (2.6) 3 (1.6) 10 (8.3)
 LTG 63 (20.4) 29 (38.2) 34 (14.6) 20 (10.6) 43 (35.5)
 LEV 16 (5.2) 6 (7.9) 10 (4.3) 2 (1.1) 14 (11.6)
 OXC 49 (15.9) 33 (43.4) 16 (6.9) 22 (22.3) 27 (22.3)
 PB 2 (0.6) 2 (0.9) 2 (1.7)
  PHT 3 (1.0) 3 (1.3) 2 (1.1) 1 (0.8)
 TGB 10 (3.2) 5 (6.6) 5 (2.1) 1 (0.5) 9 (7.4)
 TPM 36 (11.7) 16 (21.1) 20 (8.6) 8 (4.3) 28 (23.1)
 VPA 149 (48.2) 149 (48.2) 80 (42.6) 69 (57.0)
AED by group, n (%)
 1 older 132 (42.7) 132 (56.6) 132 (70.2)
 1 newer 56 (18.1) 56 (73.7) 56 (29.8)
 2 older 10 (3.2) 10 (4.3) 10 (8.3)
 2 newer 20 (6.5) 20 (26.3) 20 (16.5)
 1 older + 1 newer 91 (29.4) 91 (39.0) 91 (75.2)
a

Also includes patients on 1 newer and 1 older AED

b

Median (Q1 – the first quartile – Q3 – the third quartile)

c

Types of seizures, POS – partial onset seizures including simple partial seizures, complex partial seizures, partial onset seizures with secondary generalization alone and in combinations; PGS – primarily generalized seizures including absence, myoclonic, clonic, tonic-clonic, atonic seizures alone and in combination

d

Gender data were missing for one patient

e

Age and age at epilepsy onset data were missing for 3 patients

f

Type of seizure data were missing for 4 patients